ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 173 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $194,000 | -30.0% | 15,640 | -22.7% | 0.00% | – |
| Q3 2016 | $277,000 | +11.2% | 20,220 | -40.2% | 0.00% | – |
| Q2 2016 | $249,000 | -10.8% | 33,787 | -22.3% | 0.00% | – |
| Q1 2016 | $279,000 | +12.0% | 43,466 | +9.5% | 0.00% | – |
| Q4 2015 | $249,000 | +25.1% | 39,710 | +16.1% | 0.00% | – |
| Q3 2015 | $199,000 | -29.2% | 34,190 | +0.9% | 0.00% | – |
| Q2 2015 | $281,000 | +10.6% | 33,877 | +9.6% | 0.00% | – |
| Q1 2015 | $254,000 | +27.6% | 30,905 | +6.7% | 0.00% | – |
| Q4 2014 | $199,000 | +563.3% | 28,957 | +416.7% | 0.00% | – |
| Q3 2014 | $30,000 | -16.7% | 5,604 | 0.0% | 0.00% | – |
| Q2 2014 | $36,000 | -20.0% | 5,604 | 0.0% | 0.00% | – |
| Q1 2014 | $45,000 | +15.4% | 5,604 | -2.5% | 0.00% | – |
| Q4 2013 | $39,000 | -71.1% | 5,749 | -22.2% | 0.00% | – |
| Q3 2013 | $135,000 | +125.0% | 7,385 | +115.6% | 0.00% | – |
| Q2 2013 | $60,000 | – | 3,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |